Using a case-based approach, the lecture will review the five World Health Organization (WHO) groups of pulmonary hypertension, explaining the different underlying pathogenic mechanisms resulting in each group. The session will identify treatment approaches to each group, especially WHO group 1/pulmonary arterial hypertension. Throughout the lecture, there will be emphasis on the role of the Respiratory Therapist in the diagnosis and management of the patient.
Presented by Robert Walter, MD, MPH, FCCP
This archived webcast is approved for 1.0 CRCE Hour
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
Approved for 1.00 CRCE Hours.
SEMINAR OBJECTIVES
Review the classification and mechanisms of pulmonary hypertension
Discuss the role of the respiratory therapist in the diagnosis, risk assessment, and treatment of pulmonary hypertension
Review the pharmacologic and non-pharmacologic treatment options for pulmonary hypertension